Company News

OTC: CLCS

Stock Information

SHARE PRICE: $0.3115

VOLUME: 9,009

MARKET CAP: $13,540,345.00

SHARE COUNT: 43,468,200

DAILY HIGH: $0.3115

DAILY LOW: $0.26

OPEN: $0.295

CLOSE: $0.299

PREV. CLOSE: $0.299

CHANGE: $0.0126 (4.1980352%)

52-WEEK HIGH: $0.8401

52-WEEK LOW: $0.0002

LAST UPDATED: 9 hours ago

NEW YORK, NY / ACCESSWIRE / December 19, 2024 /Cell Source, Inc. (OTCQB:CLCS) ("Cell Source" or the "Company"), a leading innovator in immune tolerance management, recently presented promising preclinical findings at the 2024 American Society of Hematology ...

Brought to you by Yahoo! Finance
19 Dec, 2024 / 21:00

First-of-Its-Kind Success in Mismatched Donor Stem Cell Transplantation: Engraftment Under Mild Immune Suppression with Minimal Graft-versus-Host Disease NEW YORK, NY / ACCESSWIRE / November 21, 2024 /Cell Source, Inc. (OTCQB:CLCS) ("Cell Source", ...

Brought to you by Yahoo! Finance
21 Nov, 2024 / 13:00

Investor Relations Contact

Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019

+1 646 416-7896 Phone
+1 646 416-8001 Fax
Email: info@cell-source.com

Securities Counsel

Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777

Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com

Independent Auditor

Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017

Additional Information

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.